DFM Platform
DFM Funding Monitor

Revolutionary high-resolution human 3D brain organoid platform integrating AI-based analyticsbroad

3D-BrAIn · Horizon Europe grant · 2023-04-01–2028-03-31

EC contribution

€1,998,347

Total cost

€2,003,348

Beneficiaries

4
About the data

Source: CORDIS (official EU open data), Horizon Europe. Framework HORIZON · call HORIZON-EIC-2022-PATHFINDEROPEN-01 · scheme HORIZON-EIC · topic HORIZON-EIC-2022-PATHFINDEROPEN-01-01. CORDIS record →

Objective

The long-term vision of the 3D-BrAIn consortium is to revolutionize personalized precision medicine for central nervous system (CNS)disorders, by developing an innovative bio-digital twin model of the human brain that is personalized, precise, and predictive.In this pathfinder project we bring together three breakthrough technologies: 1) a novel, highly reproducible human brain modellingtechnology using robust adherent iPSC-derived 3D cortical organoid cultures, 2) a unique, state-of-the-art 3D multi-electrode array(MEA) technology for non-invasive high-resolution electrophysiological recordings and 3) a novel approach to analyse and interpretthe large quantities of functional data using tailored automated machine learning (ML)-based algorithms.With this breakthrough approach we overcome significant hurdles that made it thus far impossible to create a truly representativeand functional model of the CNS for personalized medicine, drug screening and neurotoxicity testing. The revolutionary 3D-BrAInhigh-precision CNS platform will allow robust and accurate modelling of the CNS for a broad range of neuropsychiatric diseases.Ultimately, the 3D-BrAIn technology will be translatable to multiple other organ systems (cardiomyocytes, pancreatic islets, retina), tonon-invasively obtain longitudinal 3D high-resolution electrophysiological recordings and effectively interpret them.In this project a prototype of the 3D-BrAIn platform will be developed by growing functional 3D organoids that faithfully resemblethe human cortex on 3D MEA micropillar electrodes, enabling continuous functional monitoring and by developing ML-basedalgorithms that can process and interpret the large spatiotemporal data sets. Once all individual components are optimized andintegrated, proof-of-concept will be obtained by validating the platform for two of the envisaged applications: CNS drugdevelopment and neurotoxicity screening.

Beneficiaries (4)

OrganisationCountryRoleEC contributionSME
ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM NL coordinator €1,133,750
UNIVERSITA DEGLI STUDI DI GENOVA IT participant €467,097
LUDWIG-MAXIMILIANS-UNIVERSITAET MUENCHEN DE participant €397,500
3BRAIN AG CH associatedPartner Yes

Get the DFM funding briefing — free

New EU defence calls, tenders and awards in your inbox.

Countries
Sectors
Sources

We store your email only to send the DFM briefing/alerts and to add you to DFM Analysis. Unsubscribe anytime.

Defence Finance Monitor is an analytical and informational product. Grant data is official CORDIS; payment and subscription happen on DFM Analysis.